Results 91 to 100 of about 34,105 (239)
We report a large study of the effect of BCG vaccination on the in vitro 6-day whole blood interferon-gamma (IFN-gamma) response to antigens from eight species of mycobacteria among schoolchildren in south-eastern England, where bacille Calmette-Guérin ...
Crampin, A.C. +25 more
core +1 more source
Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response. [PDF]
BACKGROUND: Tuberculosis (TB) remains a global health problem, with vaccination likely to be a necessary part of a successful control strategy. Results of the first Phase 2b efficacy trial of a candidate vaccine, MVA85A, evaluated in BCG-vaccinated ...
O’Shea, Matthew K. +44 more
core +1 more source
A Protocol of National Mixed‐Methods Assessment of Childhood and Maternal Immunization
ABSTRACT Background and Aims Accurate measurement of routine immunization coverage is essential for detecting immunity gaps, guiding programmatic responses, and supporting equitable vaccine delivery. Iran's Expanded Programme on Immunization has achieved high coverage, but administrative estimates can mask some disparities.
Seyed Aria Nejadghaderi +8 more
wiley +1 more source
The influence of BCG on vaccine responses – a systematic review
Introduction: Bacillus Calmette-Guérin (BCG) vaccine is one of the most widely used vaccines worldwide. In addition to providing protection against tuberculosis, it has non-specific (heterologous) immunomodulatory effects.
Petra Zimmermann, Nigel Curtis
doaj +1 more source
Vacuolization as a Novel Approach to Cancer Therapy
This review discusses the novel strategy of inducing vacuole formation in cancer cells using small molecules, that induce nonapoptotic cell death mechanisms, such as paraptosis, oncosis, autophagy, and methuosis, and its potential in overcoming resistance to apoptosis‐based cancer therapies.
Mariah Pasternak +9 more
wiley +1 more source
Still Standing Strong: A Narrative Review of Why BCG Remains Central to Global Tuberculosis Control
Background: Tuberculosis is one of the deadliest infectious diseases in the world. However, the BCG vaccine has shown significant results and remains in use to this day. Objective: This review aims to provide a comprehensive perspective on the resilience
Ardaniel Euprasia Simarmata +2 more
doaj +1 more source
Intravesical delivery of p21 mRNA‐loaded lipid nanoparticles (p21‐LNP) restores the tumor suppressor p21 in bladder cancer. Localized p21 expression directly induces cell cycle arrest, DNA damage and apoptosis, and ultimately inhibits orthotopic tumor growth with minimal systemic distribution and favorable safety.
Jie Zeng +3 more
wiley +1 more source
Dendritic cells (DCs) are the most potent antigen presenting cells for inducing T-cell immune responses. The ability to grow human DCs from monocyte precursors provides an abundant source of these cells, which can be modified in vitro to present antigens.
Smith, SG +7 more
core +1 more source
The Bacillus Calmette-Guérin (BCG) vaccine contains live attenuated Mycobacte-rium bovis; was first used in humans to prevent tuberculosis (TB) in 1921.
Nagi Elsidig +10 more
doaj +1 more source
Robust-gamma delta(+) T cell expansion in infants immunized at birth with BCG vaccine
Cell-mediated immune responses to BCG vaccine were evaluated in 7-month-old infants vaccinated with intradermal combined BCG and Hepatitis B or intradermal BCG and intramuscular Hepatitis B at birth.
T.N. Mazzola +23 more
core +1 more source

